SPI1 and early-onset autosomal dominant Alzheimer disease: Studies have shown that increased SPI1 expression could regulate microglial immune activity and attenuate inflammation near amyloid plaques in Alzheimer’s disease (Kim et al., 2024), suggesting its broader role in restraining aberrant immune responses.